Zhao, Y., Griesel, R., Omar, Z., Simmons, B., Hill, A., van Zyl, G., . . . Meintjes, G. (2023). Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: A noncomparative, double-blind, randomized placebo-controlled trial. Oxford University Press.
Chicago Style (17th ed.) CitationZhao, Y., R. Griesel, Z. Omar, B. Simmons, A. Hill, G. van Zyl, C. Keene, G. Maartens, and G. Meintjes. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.
MLA引文Zhao, Y., et al. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.